Centiva Capital, LP

Q2 2023 13F-HR Holdings

Location
New York, NY
Holdings as of
6/30/2023
Date filed
8/14/2023
Form type
13F-HR
Num holdings
1,583
Total value ($000)
$4,567,507
Net value change ($000)
+497,616 (12.2%)
New positions
579
Sold out positions
464
Turnover %
83.7%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Prev filing: 5/15/2023 Next filing: 11/14/2023 SEC filing

Snapshot: Change Analysis

Compared to Q1 2023
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
LQD 340,360 NEW
AAPL 19,262 324.9%
Horizon Therapeutics Public Ltd Co 19,081 232.5%
AIY 15,517 357.0%
PIONEER NATURAL RESOURCES CO 15,250 NEW
MA 12,424 NEW
HD 10,116 4268.4%
TMO 9,509 NEW
V 8,866 1724.9%
AVGO 8,398 6129.9%
Top Reduces (Value $000, Stocks/ETFs)
QQQ -65,691 -99.4%
SPY -48,157 -100.0%
VCSH -38,115 -100.0%
EMB -30,198 -100.0%
IBM -21,889 -100.0%
LMT -17,653 -98.3%
BN -16,374 -36.7%
MRK -13,924 -100.0%
Amryt Pharma plc -11,514 -100.0%
PM -11,507 -100.0%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 2,592,032 (56.7% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type